Highlights and Quick Summary
- Cash per Share for the quarter ending September 30, 2022 was 4.0 (a -18.02% decrease compared to previous quarter)
- Year-over-year quarterly Cash per Share decreased by -30.98%
- Annual Cash per Share for 2021 was 5.8 (a 12.65% increase from previous year)
- Annual Cash per Share for 2020 was 5.15 (a -0.96% decrease from previous year)
- Annual Cash per Share for 2019 was 5.2 (a -26.42% decrease from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash per Share of BridgeBio Pharma, Inc.
Most recent Cash per Shareof BBIO including historical data for past 10 years.Interactive Chart of Cash per Share of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. Cash per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 4.0 | 4.88 | 4.6 | – |
| 2021 | 5.8 | 4.09 | 5.71 | 6.63 | 5.8 |
| 2020 | 5.15 | 6.01 | 7.19 | 7.68 | 5.15 |
| 2019 | 5.2 | 4.58 | 0.0 | 0.0 | 5.2 |
| 2018 | – | – | 0.0 | 0.0 | 7.06 |
| 2017 | – | – | – | – | 3.01 |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology